Mobocertinib is an oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations. Reference standards of Mobocertinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Mobocertinib
Catalogue No.:PA 13 2900000
CAS :
Molecular Formula : C32H39N7O4
Molecular Weight : 585.71
Isopropyl 2-((5-acrylamido-4-((2-(dimethylamino)ethyl)(nitroso)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
Catalogue No.:PA 13 2901000
Molecular Formula : C31H36N8O5
Molecular Weight : 600.68
Isopropyl 2-((5-acrylamido-4-((2-(dimethylamino)ethyl)(nitroso)amino)-2-methoxyphenyl)(nitroso)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
Catalogue No.:PA 13 2901001
Molecular Formula : C31H35N9O6
Molecular Weight : 629.68
Isopropyl 2-((5-acrylamido-2-methoxy-4-(methyl(2-(methyl(nitroso)amino)ethyl)amino)phenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
Catalogue No.:PA 13 2901002
Isopropyl 2-((5-acrylamido-2-methoxy-4-(methyl(2-(methyl(nitroso)amino)ethyl)amino)phenyl)(nitroso)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
Catalogue No.:PA 13 2901003
Isopropyl 2-((5-acrylamido-2-methoxy-4-((2-(methyl(nitroso)amino)ethyl)(nitroso)amino)phenyl)(nitroso)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
Catalogue No.:PA 13 2901004
Molecular Formula : C30H32N10O7
Molecular Weight : 644.65
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
